RESUMO
Cystic fibrosis is one of the most common autosomal recessive genetic disorders in caucasians of Northern European descent, affecting approximately 30 000 children and adults living in the United States, today. Complications of this chronic disease result in deterioration of lung function and development of pancreatic abnormalities requiring pharmacological therapy and may include patients seeking complementary and alternative option for treatment. Health care professionals should be knowledgeable of these therapies to effectively provide education and drug therapy management. This article offers an overview of the most common complementary therapies in cystic fibrosis such as vitamin A, vitamin C, vitamin E, zinc, omega 3 fatty acids, docosahexaenoic acid (DHA), garlic, ginseng, and curcumin.
Assuntos
Antioxidantes/uso terapêutico , Fibrose Cística/tratamento farmacológico , Suplementos Nutricionais , Fitoterapia/métodos , Antioxidantes/administração & dosagem , Antioxidantes/efeitos adversos , Ácido Ascórbico/uso terapêutico , Curcumina/uso terapêutico , Ácidos Docosa-Hexaenoicos/uso terapêutico , Ácidos Graxos Ômega-3/uso terapêutico , Alho , Humanos , Panax , Vitamina A/uso terapêutico , Vitamina E/uso terapêutico , Zinco/uso terapêuticoRESUMO
Annually there are 500 000 preventable deaths in the United States caused by smoking; as health care professionals, pharmacists have a unique opportunity to advise, assess, and assist patients to quit smoking. This review article provides pharmacists with a "toolbox" containing an overview of pharmacologic and nonpharmacologic methods for smoking cessation. Currently approved over-the-counter (OTC) and prescription medications (nicotine replacement therapy, varenicline, and bupropion) are summarized, and nonpharmacologic therapies discussed include cognitive therapy and hypnosis. In addition to traditional therapies some potential approaches to smoking cessation are addressed, including nicotine immunizations and electronic cigarettes.